<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30235654</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>03</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1536-5964</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>97</Volume>                    <Issue>38</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                    </PubDate>                </JournalIssue>                <Title>Medicine</Title>                <ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation>            </Journal>            <ArticleTitle>The efficacy of gabapentin in reducing pain intensity and morphine consumption after breast cancer surgery: A meta-analysis.</ArticleTitle>            <Pagination>                <MedlinePgn>e11581</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000011581</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The purpose of this meta-analysis from randomized controlled trials (RCTs) was to determine the efficacy and safety of the preoperative use of gabapentin for the treatment of acute and chronic postoperative pain following breast cancer surgery.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">In November 2017, a systematic computer-based search was conducted in PubMed, Embase, Web of Science, Cochrane Library, and Google databases. RCTs comparing gabapentin with placebo in patients undergoing breast cancer surgery were retrieved. The primary endpoint was the visual analog scale (VAS) after surgery and 24 hours after surgery and total morphine consumption. The secondary outcomes were incidence of chronic pain and complications (the incidence of nausea). Software Stata 12.0 was used for meta-analysis.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Finally, 9 RCTs were included in the meta-analysis. Results indicated that gabapentin was associated with reduced pain scores after surgery and 24 hours after surgery. Meanwhile, oral gabapentin was associated with a reduction of the total morphine consumption after breast cancer surgery. Similarly, gabapentin was associated with a reduction in the incidence of chronic pain and the incidence of nausea.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Preoperative use of gabapentin was able to reduce acute and chronic postoperative pain, total morphine consumption and the occurrence of nausea following breast cancer surgery. Further studies should determine the optimal dose of gabapentin for pain control after breast cancer surgery.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Jiang</LastName>                    <ForeName>Yunfeng</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Oncology Department, The First Affiliated Hospital of Guangxi University of Chinese Medicine.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Li</LastName>                    <ForeName>Junhong</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Medical Ethics Committee.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lin</LastName>                    <ForeName>Huasheng</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Spleen and Stomach Liver Disease, Nanning, Guangxi.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Huang</LastName>                    <ForeName>Qiaotong</ForeName>                    <Initials>Q</Initials>                    <AffiliationInfo>                        <Affiliation>Oncology Department, The First Affiliated Hospital of Guangxi University of Chinese Medicine.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wang</LastName>                    <ForeName>Tongbiao</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Oncology Department, The First Affiliated Hospital of Guangxi University of Chinese Medicine.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Shijie</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Oncology Department, The First Affiliated Hospital of Guangxi University of Chinese Medicine.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Qing</ForeName>                    <Initials>Q</Initials>                    <AffiliationInfo>                        <Affiliation>College of Education Science, Guangxi Teachers Education University, Nanning.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rong</LastName>                    <ForeName>Zheng</ForeName>                    <Initials>Z</Initials>                    <AffiliationInfo>                        <Affiliation>Oncology Department, The First Affiliated Hospital of Guangxi University of Chinese Medicine.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Xiong</LastName>                    <ForeName>Jun</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Acupuncture and Moxibustion, The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi, China.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D017418">Meta-Analysis</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Medicine (Baltimore)</MedlineTA>            <NlmUniqueID>2985248R</NlmUniqueID>            <ISSNLinking>0025-7974</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000588">Amines</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D003509">Cyclohexanecarboxylic Acids</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>56-12-2</RegistryNumber>                <NameOfSubstance UI="D005680">gamma-Aminobutyric Acid</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>6CW7F3G59X</RegistryNumber>                <NameOfSubstance UI="C040029">gabapentin</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>76I7G6D29C</RegistryNumber>                <NameOfSubstance UI="D009020">Morphine</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>AIM</CitationSubset>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>J Plast Reconstr Aesthet Surg. 2017 Oct;70(10):1317-1328</RefSource>                <PMID Version="1">28751024</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asia Pac J Clin Oncol. 2018 Feb;14(1):32-39</RefSource>                <PMID Version="1">28815913</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ. 2008 Apr 26;336(7650):924-6</RefSource>                <PMID Version="1">18436948</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Surg. 2017 Aug;44:122-127</RefSource>                <PMID Version="1">28642088</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pain. 2014 Feb;155(2):232-43</RefSource>                <PMID Version="1">24099954</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin J Pain. 1996 Mar;12(1):50-5</RefSource>                <PMID Version="1">8722735</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biometrics. 1977 Jun;33(2):363-74</RefSource>                <PMID Version="1">884196</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Medicine (Baltimore). 2017 Sep;96(37):e8007</RefSource>                <PMID Version="1">28906382</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Anaesthesiol Taiwan. 2013 Mar;51(1):10-3</RefSource>                <PMID Version="1">23711599</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anesth Analg. 2005 Nov;101(5):1427-32</RefSource>                <PMID Version="1">16244006</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Neurol. 2017 Dec;24(12):1446-1456</RefSource>                <PMID Version="1">28888061</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ. 2009 Jul 21;339:b2700</RefSource>                <PMID Version="1">19622552</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pain Palliat Care Pharmacother. 2006;20(4):79-84</RefSource>                <PMID Version="1">17182514</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Musculoskelet Disord. 2016 Aug 30;17(1):373</RefSource>                <PMID Version="1">27577678</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anesthesiology. 2002 Sep;97(3):560-4</RefSource>                <PMID Version="1">12218520</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin J Pain. 2010 Jun;26(5):381-5</RefSource>                <PMID Version="1">20473044</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Minerva Anestesiol. 2010 Oct;76(10):805-13</RefSource>                <PMID Version="1">20935616</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Medicine (Baltimore). 2016 May;95(20):e3673</RefSource>                <PMID Version="1">27196473</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ. 2008 May 3;336(7651):995-8</RefSource>                <PMID Version="1">18456631</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anesth Analg. 2002 Oct;95(4):985-91, table of contents</RefSource>                <PMID Version="1">12351281</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Postgrad Med. 2009 Oct-Dec;55(4):257-60</RefSource>                <PMID Version="1">20083871</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Anaesthesiol. 2000 Sep;17(9):566-75</RefSource>                <PMID Version="1">11029124</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pain Res Manag. 2009 May-Jun;14(3):217-22</RefSource>                <PMID Version="1">19547761</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Anaesthesiol. 2016 Mar;33(3):204-14</RefSource>                <PMID Version="1">26760402</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Medicine (Baltimore). 2017 Aug;96(31):e7714</RefSource>                <PMID Version="1">28767611</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pain. 1996 Dec;68(2-3):343-7</RefSource>                <PMID Version="1">9121823</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Bone Joint Surg Am. 2016 Aug 17;98(16):1340-50</RefSource>                <PMID Version="1">27535436</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biometrics. 1977 Mar;33(1):159-74</RefSource>                <PMID Version="1">843571</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Arthroplasty. 2015 Jul;30(7):1281-6</RefSource>                <PMID Version="1">25735501</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2006 May 13;367(9522):1618-25</RefSource>                <PMID Version="1">16698416</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Medicine (Baltimore). 2017 Apr;96(15):e6463</RefSource>                <PMID Version="1">28403075</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Dermatolog Treat. 2017 Feb;28(1):65-77</RefSource>                <PMID Version="1">27798973</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pain Med. 2017 Jul 1;18(7):1344-1365</RefSource>                <PMID Version="1">27550949</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000588" MajorTopicYN="N">Amines</DescriptorName>                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D059350" MajorTopicYN="N">Chronic Pain</DescriptorName>                <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003509" MajorTopicYN="N">Cyclohexanecarboxylic Acids</DescriptorName>                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008408" MajorTopicYN="N">Mastectomy</DescriptorName>                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009020" MajorTopicYN="N">Morphine</DescriptorName>                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D010147" MajorTopicYN="N">Pain Measurement</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D010149" MajorTopicYN="N">Pain, Postoperative</DescriptorName>                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005680" MajorTopicYN="N">gamma-Aminobutyric Acid</DescriptorName>                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>22</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>22</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>4</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30235654</ArticleId>            <ArticleId IdType="doi">10.1097/MD.0000000000011581</ArticleId>            <ArticleId IdType="pii">00005792-201809210-00002</ArticleId>            <ArticleId IdType="pmc">PMC6160249</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>